1Zhang BH,Pan XP,Anderson TA. MicroRNA:a new player in stem cells [J]. Cell Physiol,2006 ;209(2):266-9.
2Tanno B, Ces IV, Vitali R, et al. Silencing of endogenous IGFBP2 5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastnma cells [J].Cell Death Differ,2005 ; 12 ( 3 ) :213-23.
3Alvarez, Garcia I, Miska EA, MicroRNA functions in animal development and human disease [J].Development,2005 ; 132 (21 ) :4653-62.
4Volinia S, Calin GA, Liu CG, et al. A microRNA expression singnture of human solid tumors deftnes cancer gene targets [J]. Proc Natl Acad Sci USA ,2006 ; 103 ( 13 ) :2257-61.
5Lira LP, Lau NC, Weinstein EG, et al. The microRNAs of caenorhabditis elegans[J].Genes Dev ,2003 ; 17 ( 8 ) :991-1008.
6Glrad Y, Aaeh J, Hayes GD, et al. Computational and experimental identi- fication of C. elegans microRNAs[J]. Mol Cell,2003 ; 11 ( 5 ) : 1253 -63.
7Bentwich I. Identification of hundreds of conserved and nonconserved human microRNAs [J]. Nat Genet ,2005 ;37 : 766-70.
9Martin MM, Buckenberger JA, Jiang J, et al. The human angiotensin II type I receptor + 1166A/C polymorphism attenuates microRNA-155 Binding [J]. Biol Chem,2007 ;282 ( 33 ) :2426-9.
10Long D, Chan CY, Ding Y. Analysis of microRNA-target interactions by a target structure based hybridization model[J].Pac Syrup Biocomput, 2008 : 64 -74.
同被引文献33
1Calin GA, Croce CM. MicroRNA si.atures in human cancers. Nat Rev Cancer, 2006, 6(11): 857-866.
2Lu J, Getz G, Miska EA, et al. MieroRNA expression profiles classi- fy human cancers. Nature, 2005, 435(7043): 834-838.
3Li Y, Li W, Ouyang Q, et al. Detection of lung cancer with blood microRNA-21 expression levels in Chinese population. Oncol Lett, 2011, 2(5): 991-994.
4Adam L, Wszolek MF, Liu CG, et al. Plasma microRNA profiles for bladder cancer detection. Urol Oncol, [2012-08-06]. http://www. urologiconcology, org/crticle/S1078-1439 ( 12 )00236-0/abstract.
5Li BS, Zhao YL, Guo G, et al. Plasma mieroRNAs, miR-223, miR-21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One, 2012, 7(7): e41629.
6Hou J, Lin L, Zhou W, et al. Identification of miRNomes in hmnan liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell, 2011, 19(2) : 232-243.
7Pichler M, Winter E, Stotz M, et al. Down-regulation of KRAS- interacting miRNA-143 predicts poor prognosis but not response to ECR-targeted agents in eolorectal cmm. BrJ Cancer, 2012, 106(11): 1826-1832.
8Riordan AM, Thomas MK, Ronnekleiv-Kelly S, et al. Utility of mi- cro-ribonucleic acid profile for predicting recurrence of rectal cancer. J Surg Res, 2012, 177(1): 87-92.
9Kuo TY, Hsi E, Yang IP, et al. Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorec- tal cancer early recurrence. PLoS One, 2012, 7(2) : e31587.
10Cookson VJ, Bentley MA, Hogan BV, et al. Circulating microRNA profiles reflect the presence of breast attrurs but not the profiles of micmRNAs within the turnouts. Cell Oneol (Doldr), 2012, 35(4): 301-308.
